Overview
|
What is Quannabu
Quannabu Labs aims to be the largest manufacturer of hemp-derived products in Europe within the next three years, producing pharmaceutical-grade CBD under GMP conditions. With the combination of its blockchain technology – providing unprecedented levels of transparency across the entire CBD supply chain – cutting-edge laboratories, and legal growing facilities, it will be one of the very few GMP certified suppliers in the world able to supply assured, fully traceable, and lab-tested CBD at scale. Benefiting consumers and companies in the nutraceutical, food and beverage, and health industries the world over.
DetailsIEO (Exmarkets Launchpad): May 17, 2021 - Jun 27, 2021IEO (Latoken Launchpad): May 17, 2021 - Jul 30, 2021 Token supply: 30,000,000 QBU Total tokens for sale: 15,000,000 QBU Hard cap: 15,000,000 USD LegalBlockchain Platform: EthereumCountry limitations: China; Iran; North Korea; other OFAC countries; USA Registration country: United Kingdom Registration year: 2021 Office address: 71-75 Shelton Street, London, WC2H 9JQ. United Kingdom | Token infoTicker: QBUToken standard: ERC-20 Token price in USD: 1 BRT =1 OBU Token distribution: 10% - Team and Advisers 10% - Future Strategy Partnerships 20% - Reserve 10% - Future Development 50% - Token Sale |
Quannabu Roadmap
1
Year 1
2
Year 2
3
Year 3
4
Year 4
Project team
STEVE SHEARING
Chief Executive Officer
CHRIS SMITH
KAL VAUGHAN
Marketing
ANTHONY SMITH
Technical Director